An inhibitor of cell proliferation associated with adhesion formation is suppressed by N,O-carboxymethyl chitosan

Journal of Investigative Surgery

Volumn 11, Issue 2, 1998, Pages 105-113

  Krause, Tyrone J ^a,c   Goldsmith, Noriko Kane ^a   Ebner, Sylvie ^a   Zazanis, George A ^a   McKinnon, Randall D ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Adhesions; Animals; N,O carboxymethyl chitosan; Prevention; Surgery; Transforming growth factor beta

Indexed keywords

ANTIMITOTIC AGENT; CHITOSAN DERIVATIVE; CYTOKINE; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADHESION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FIBROSIS; INFLAMMATORY INFILTRATE; MALE; MESOTHELIUM; NONHUMAN; PERITONEUM EXUDATE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0031874786     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.3109/08941939809032189     Document Type: Article

References (47)

1. Buckman RF, Woods M, Sargent L, Gervin AS. A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J Surg Res. 1976;20:1-5.
2. Buckman RFJ, Buckman PD, Hufnagel HV, Gervin AS. A physiologic basis for the adhesion-free healing of deperitonealized surfaces. J Surg Res. 1976;21:67-76.
3. Raftery AT. Regeneration of parietal and visceral peritoneum: An electron microscopical study. J Anat. 1973; 115:375-392.
4. Raftery AT. An enzyme histochemical study of mesothelial cells in rodents. J Anat. 1973;115:365-373.
5. Raftery AT. Regeneration of peritoneum: A fibrinolytic study. J Anat. 1979;129:659-664.
6. Strange C, Tomlinson JR, Wilson C, Harley R, Miller KS, Sahn SA. The histology of experimental pleural injury with tetracycline, empyema, and carrageenan. Exp Mol Pathol. 1989;51:205-219.
7. Leak LV, Ferrans VJ, Cohen SR, Eidbo EE, Jones M. Animal model of acute pericarditis and its progression to pericardial fibrosis and adhesions: Ultrastructural studies. Am J Anat. 1987;180:373-390.
8. Holmdahl L, Risberg B, Beck DE, Burns JW, Chegini N, diZerega GS, Ellis H. Adhesions: Pathogenesis and prevention - Panel discussion and summary. Eur J Surg Suppl. 1997;56-62.
9. Gabbay S, Guindy AM, Andrews JF, Amato JJ, Seaver P, Khan MY. New outlook on pericardial substitution after open heart operations. Ann Thorac Surg. 1989;48:803-812.
10. Bunton RW, Xabregas AA, Miller AP. Pericardial closure after cardiac operations. An animal study to assess currently available materials with particular reference to their suitability for use after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1990;100:99-107.
11. Eng J, Ravichandran PS, Abbott CR, Kay PH, Murday AJ, Shreiti I. Reoperation after pericardial closure with bovine pericardium. Ann Thorac Surg. 1989;48:813-815.
12. Young RL, Cota J, Zund G, Mason BA, Wheeler JM. The use of an amniotic membrane graft to prevent postoperative adhesions. Fertil Steril. 1991;55:624-628.
13. Heydorn WH, Daniel JS, Wade CE. A new look at pericardial substitutes. J Thorac Cardiovasc Surg. 1987;94:291-296.
14. Vander Salm TJ, Okike ON, Marsicano TH, Compton C, Espinoza E. Prevention of postoperative pericardial adhesions. An animal study. Arch Surg. 1986;121:462-467.
15. Revuelta JM, Garcia-Rinaldi R, Val F, Crego R, Duran CM. Expanded polytetrafluoroethylene surgical membrane for pericardial closure. An experimental study. J Thorac Cardiovasc Surg. 1985;89:451-455.
16. Risberg B. Adhesions: Preventive strategies. Eur J Surg Suppl. 1997;32-39.
17. Pennisi E. Chitin craze. Science News. 1993;144:72-74.
18. Krause TJ, Zazanis GA, McKinnon RD. Prevention of post-operative adhesions with the chitin derivative N,O-carboxymethyl chitosan. Wound Repair and Regeneration. 1996;4:53-57.
19. Kennedy R, Costain DJ, McAlister VC, Lee TD. Prevention of experimental postoperative peritoneal adhesions by N,O-carboxymethyl chitosan. Surgery. 1996;120:866-870.
20. Costain DJ, Kennedy R, Ciona C, McAlister VC, Lee TD. Prevention of postsurgical adhesions with N,O-carboxymethyl chitosan: Examination of the most efficacious preparation and the effect of N,O-carboxymethyl chitosan on postsurgical healing. Surgery. 1997;121:314-319.
21. Docherty R, Forrester JV, Lackie JM, Gregory DW. Glycosaminoglycans facilitate the movement of fibroblasts through three-dimensional collagen matrices. J Cell Sci. 1989;92:263-270.
22. Gessin JC, Brown LJ, Gordon JS, Berg RA. Regulation of collagen synthesis in human dermal fibroblasts in contracted collagen gels by ascorbic acid, growth factors, and inhibitors of lipid peroxidation. Exp Cell Res. 1993;206:283-290.
23. Klein NJ, Shennan GI, Heyderman RS, Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci. 1992;102:821-832.
24. Huang-Lee LL, Nimni ME. Fibroblast contraction of collagen matrices with and without covalently bound hyaluronan. J Biomater Sci Polym Ed. 1993;5:99-109.
25. Brecht M, Mayer U, Schlosser E, Prehm P. Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J. 1986;239:445-450.
26. Heldin P, Laurent TC, Heldin CH. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J. 1989;258:919-922.
27. Miller DA, Pelton RW, Derynck R, Moses HL. Transforming growth factor-β. A family of growth regulatory peptides. Ann N Y Acad Sci. 1990;593:208-217.
28. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
29. Chegini N, Gold LI, Williams RS, Masterson BJ. Localization of transforming growth factor β isoforms TGF-β1, TGF-β2, and TGF-β3 in surgically induced pelvic adhesions in the rat. Obstet Gynecol. 1994;83:449-454.
30. Chang J, Most D, Stelnicki E, Siebert JW, Longaker MT, Hui K, Lineaweaver WC. Gene expression of transforming growth factor β-1 in rabbit zone II flexor tendon wound healing: Evidence for dual mechanisms of repair. Plast Reconstr Surg. 1997;100:937-944.
31. Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB. Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Physiol. 1989;138:79-86.
32. McKinnon RD, Piras G, Ida JA, Jr, Dubois-Dalcq M. A role for TGF-β in oligodendrocyte differentiation. J Cell Biol. 1993;121:1397-1407.
33. Laiho M, Weis MB, Massague J. Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem. 1990;265:18518-18524.
34. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol. 1987;105:1039-1045.
35. Roberts AB, Heine UI, Flanders KC, Sporn MB. Transforming growth factor-β. Major role in regulation of extracellular matrix. Ann N Y Acad Sci. 1990;580:225-232.
36. Chegini N, Simms J, Williams RS, Masterson BJ. Identification of epidermal growth factor, transforming growth factor-α, and epidermal growth factor receptor in surgically induced pelvic adhesions in the rat and intraperitoneal adhesions in the human. Am J Obstet Gynecol. 1994;171:321-327.
37. Chegini N. The role of growth factors in peritoneal healing: transforming growth factor β (TGF-beta). Eur J Surg Suppl. 1997;17-23.
38. Dou Q, Williams RS, Chegini N. Inhibition of transforming growth factor-β1 alters the growth, anchor-dependent cell aggregation and integrin mRNA expression in human promonocytes: Implications for endometriosis and peritoneal adhesion formation. Mol Hum Reprod. 1997;3:383-391.
39. Williams RS, Rossi AM, Chegini N, Schultz G. Effect of transforming growth factor β on postoperative adhesion formation and intact peritoneum. J Surg Res. 1992;52:65-70.
40. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
41. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA. 1993;90:770-774.
42. Orita H, Fukasawa M, Girgis W, diZerega GS. Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal treatment with tissue plasminogen activator. Int J Fertil. 1991;36:172-177.
43. Holmdahl LE, Al-Jabreen M, Risberg B. Role of fibrinolysis in the formation of postoperative adhesions. Wound Repair Regenerat. 1994;2:171-176.
44. Nkere UU, Whawell SA, Sarraf CE, Schofield JB, Thompson JN, Taylor KM. Perioperative histologic and ultrastructural changes in the pericardium and adhesions. Ann Thorac Surg. 1994;58:437-444.
45. Wiseman DM, Kamp L, Linsky CB, Jochen RF, Pang RH, Scholz PM. Fibrinolytic drugs prevent pericardial adhesions in the rabbit. J Surg Res. 1992;53:362-368.
46. Holmdahl L. The role of fibrinolysis in adhesion formation. Eur J Surg Suppl. 1997;24-31.
47. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315-328.